Company intelligence / Profile preview

Corrib Master Fund

George Town, Cayman Islands

Ownership: Private
Development stage: Other

Overview

Corrib Master Fund, Ltd. is a hedge fund established in the Cayman Islands and managed by Corrib Capital Management, LP. It functions as a pooled investment vehicle, investing in public companies with no direct involvement in drug discovery, biotechnology, pharmaceuticals, or healthcare product development. It is not active in developing therapeutics or healthcare platforms, and it is not a life science or biotech company in any clinical or research sense[1][3][4][5].

Industry: Investors

Beyond the preview

Go deeper on Corrib Master Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corrib Master Fund.

Explore the full profile